Minimising our Environmental Impacts

CSL has an Environment, Health, Safety and Sustainability (EHS2) Strategic Plan which ensures its facilities operate to industry and regulatory standards. This strategy includes compliance with government regulations and commitments to continuously improve the health and safety of the workforce as well as minimising the impact of operations on the environment. To drive this strategy, an internal Global CSL EHS2 Management System (EHS2MS) Standard has been developed and gives regard to the international standards, ISO 14001 Environmental Management Systems and draft ISO 45001 Occupational Health and Safety Management Systems.

No environmental breaches have been notified by the Environment Protection Authority in Victoria, Australia or by any other equivalent Australian interstate or foreign government agency in relation to CSL’s Australian, European, North American or Asia Pacific operations during the year ended 30 June 2017.

For 2016/17, increasing production output is reflected in an increasing environmental footprint, however environmental initiatives, together with increasing use of the production capacity of recently built plants, led to decreasing energy, GHG and water intensities. Nonetheless, CSL’s facilities still require significant amounts of energy and water for operational procedures such as test runs, validation of equipment and operation when not at full capacity. Furthermore, HVAC energy consumption for clean room areas is nearly independent of production output. CSL continues to be challenged by its expanding manufacturing footprint, which is growing to help meet product demand and deliver new and improved therapies to patients.

Our Environmental Impact Trends

In 2015/16, CSL increased its footprint from five to seven manufacturing sites following the acquisition of the Novartis influenza vaccine business. For comparative purposes, we have provided data from 2013 to 2015 which excludes the Novartis influenza vaccine acquired sites.






Energy Consumption2Petajoules (PJ)




2.87 3.17
Greenhouse Gas Emmissions3Kilotonnes CO2-e (KT)




303 334
Water ConsumptionGigalitres (GL)




3.14 3.43
Total WasteKilotonnes (KT)




44.076 33.07
Waste Recycling Rate4Percentage %




527 51
1 Data reported, with offsets, are inclusive of manufacturing sites located in Bern (Switzerland), Marburg (Germany), Kankakee (US), Parkville (Australia) and Broadmeadows (Australia), CSL Plasma, CSL Behring headquarters (King of Prussia, US). Offsets are supply of energy to third parties on or near a CSL production site. Included offsets are scope 1 & 2 energy supplies only.
2 Includes scope 1 & 2 energy sources. Scope 1 energy sources are fossil energy sources supplied or used on site. Scope 2 energy sources are electricity, steam, compressed air and nitrogen used on site.
3 The major greenhouse gas (GHG) emitted from CSL’s operation is carbon dioxide (CO2). In USA, Germany, UK and Switzerland, GHG emission factors are used to calculate CO2 emissions only. In Australia, GHG emission factors used by CSL calculate carbon dioxide, nitrous oxide and methane emissions. Total emissions for Australian facilities are expressed as carbon dioxide equivalents (CO2-e).
4 The recycling rate represents the proportion of total waste generated that is either reused or recycled.
5 In addition to note 1 above, data from 2015/16 onwards includes the two new Seqirus manufacturing sites at Holly Springs (US) and Liverpool (UK).
6 Waste totals include the two new Seqirus manufacturing sites at Holly Springs (US) and Liverpool (UK). Total 2015/16 includes construction based waste driven by CSL’s manufacturing expansion activities.
7 Data has been restated downwards following the adjustment of an internal formula.